R. D. Anderson

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial

Amit N. Patel, G. Ewald, M. Farr, 2015, European heart journal.

"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.

R. Neuwirth, K. Sullivan, L. Sutton, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.